ASP Drug Pricing - (3rd Quarter)
July 2024
Payment Allowance Limits for Medicare Part B Drugs

  • Note 1: Payment allowance limits subject to the ASP methodology are based on Jan 2024 (1st Quarter) ASP data.
  • Note 2: The absence or presence of a HCPCS code and the payment allowance limits in this table does not indicate Medicare coverage of the drug. Similarly, the inclusion of a payment allowance limit within a specific column does not indicate Medicare coverage of the drug in that specific category. These determinations shall be made by the local Medicare contractor processing the claim.
 
Page 11 * Effective Jul 1, 2024 through Sep 30, 2024
HCPCS Code Code Dosage Payment
Limit		 Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
J1932 - Injection, lanreotide, (cipla), 1 mg 1 MG 42.343 - - - - - -
J1939 - Injection, bumetanide, 0.5 mg 0.5 MG 0.615 - - - - - -
J1940 - Injection, furosemide, up to 20 mg 20 MG 0.438 - - - - - -
J1943 - Injection, aripiprazole lauroxil, (aristada initio), 1 mg 1 MG 3.144 - - - - - -
J1944 - Injection, aripiprazole lauroxil, (aristada), 1 mg 1 MG 3.224 - - - - - -
J1950 - Injection, leuprolide acetate (for depot suspension), per 3.75 mg 3.75 MG 1673.933 - - - - - -
J1951 - Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg 0.25 MG 140 - - - - - -
J1952 - Leuprolide injectable, camcevi, 1 mg 1 mg 55.637 - - - - - -
J1953 - Injection, levetiracetam, 10 mg 10 MG 0.055 - - - - - -
J1954 - Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg 7.5 MG 306.658 - - - - - -
J1955 - Injection, levocarnitine, per 1 gm 1 GM 30.542 - - - - - -
J1956 - Injection, levofloxacin, 250 mg 250 MG 0.935 - - - - - -
J1961 - Injection, lenacapavir (only for use as hiv treatment), 1 mg 1 MG 21.917 - - - - - -
J2001 - Injection, lidocaine hcl for intravenous infusion, 10 mg 10 MG 0.026 - - - - - -
J2010 - Injection, lincomycin hcl, up to 300 mg 300 MG 9.948 - - - - - -
J2020 - Injection, linezolid, 200 mg 200 MG 2.621 - - - - - -
J2021 - Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg 200 MG 14.342 - - - - - -
J2060 - Injection, lorazepam, 2 mg 2 MG 1.307 - - - - - -
J2150 - Injection, mannitol, 25% in 50 ml 50 ML 2.893 - - - - - -
J2175 - Injection, meperidine hydrochloride, per 100 mg 100 MG 6.022 - - - - - -
J2182 - Injection, mepolizumab, 1 mg 1 MG 30.459 - - - - - -
J2183 - Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg 100 MG 1.601 - - - - - -
J2184 - Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg 100 MG 2.107 - - - - - -
J2185 - Injection, meropenem, 100 mg 100 MG 0.321 - - - - - -
J2210 - Injection, methylergonovine maleate, up to 0.2 mg 0.2 MG 20.792 - - - - - -
* Effective Jul 1, 2024 through Sep 30, 2024

Drugs not otherwise classified - July 2024

 

Medicare Part B payment allowance limits for drugs not otherwise classified - Effective Jul 1, 2024 through Sep 30, 2024

Drug name Dosage Payment limit Notes
Aminocaproic acid 250 MG 0.303
Aztreonam 500 MG 2.128
Benzylpenicillin Benzathine (Extencilline) 100,000 UNITS 16.308 Added July 2024
Diltiazem Hydrochloride 5 MG 0.374
Doxycycline Hyclate 100 MG 13.505
Famotidine 10 MG 0.3
Flumazenil 0.1 MG 1.123
Folic Acid 5 MG 2.808
Furosemide (Phlow Corporation) 20 MG 1.579
Glucarpidase 10 UNITS 399.73
Glycopyrrolate injection (Fresenius Kabi) 0.1 MG 2.698 providers must check the crosswalk file to determine the correct payment allowance
Metoprolol Tartrate 1 MG 0.136
Rifampin 600 MG 49.595
Sodium Chloride, Hypertonic (3% - 5% infusion) 250 CC 1.432
Sulfamethoxazole-Trimethoprim 400-80 MG 0.572

ASP (Average Sale Price) Drug Pricing History